ARCT
USDArcturus Therapeutics Holdings Inc. Common Stock
$13.780-0.380 (-2.684%)
即時價格
Healthcare
生物科技
美國
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$14.160
最高
$14.435
最低
$13.620
交易量
0.25M
公司基本面
市值
373.7M
行業
生物科技
國家
United States
交易統計
平均交易量
0.46M
交易所
NGM
貨幣
USD
52週範圍
最低 $8.04當前 $13.780最高 $25.88
相關新聞
Analyst Upgrades
Scotiabank Maintains Sector Outperform on Arcturus Therapeutics, Raises Price Target to $35
Scotiabank analyst Greg Harrison maintains Arcturus Therapeutics with a Sector Outperform and raises the price target from $32 to $35.
查看更多
BusinessWire
Arcturus Therapeutics Announces Positive Interim Phase 2 Multiple Dose Data for Ornithine Transcarbamylase (OTC) Deficiency Program
ARCT-810 significantly and consistently reduces biomarker glutamine to levels within normal range 15N-ureagenesis data provide first evidence of an mRNA therapeutic improving urea cycle function Ammonia remained
查看更多
BusinessWire
Arcturus Therapeutics to Host Key Opinion Leader (KOL) Presentation of ARCT-810 Phase 2 Interim Data for Ornithine Transcarbamylase (OTC) Deficiency
Arcturus Therapeutics Holdings Inc. ((the "Company", "Arcturus", NASDAQ:ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and
查看更多
相關股票
保持更新
設定價格提醒，獲取AI分析更新和即時市場新聞。